Simeprevir Sodium Patent Expiration
Simeprevir Sodium is Used for treating hepatitis C. It was first introduced by Janssen Products Lp
Simeprevir Sodium Patents
Given below is the list of patents protecting Simeprevir Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Olysio | US8148399 | Macrocyclic inhibitors of hepatitis C virus | Sep 05, 2029 | Janssen Prods |
| Olysio | US8349869 | Macrocylic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US8741926 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US8754106 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9040562 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9353103 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9623022 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9856265 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US7671032 | HCV NS-3 serine protease inhibitors | May 19, 2025 | Janssen Prods |
Simeprevir Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List